...
首页> 外文期刊>Journal of pharmaceutical investigation >Nanoemulsions loaded Carbopol? 934 based gel for intranasal delivery of neuroprotective Centella asiatica extract: in-vitro and ex-vivo permeation study
【24h】

Nanoemulsions loaded Carbopol? 934 based gel for intranasal delivery of neuroprotective Centella asiatica extract: in-vitro and ex-vivo permeation study

机译:纳米乳液负载Carbopol? 934基凝胶可用于鼻内神经保护积雪草提取物的鼻内给药:体外和离体渗透研究

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The objective of the present study was to develop a formulation for sustained release of phytothera-peutics through nasal membrane for brain targeting (anti-Alzheimer) in order to overcome their low residence time and poor nasal permeability issues. A dual approach containing nanoemulsions within gel (NE-gels) was used to achieve the objectives utilizing biocompatible biomateri-als. Nanoemulsions were characterized for particle size and zeta potential. NE-gels loaded with Centella asiatica (CA) extract were developed using Carbopol? 934 and were characterized for rheological properties (spreadability, viscosity), drug release and prolong anti-oxidant profile. In vitro nasal permeation and free radical scavenging activity were performed to investigate their expected sustained pharmacological responses. With increasing Carbopol content, viscosity of NE-gels was found to increase up to 6237.3 ± 1.1 cp which adversely influenced the spreadability (3.06 ± 0.98) of the NE-gels. Enhancement in sustained release of the CA extract across the nasal membrane (four fold; up to 48 h) as well as retention time in nasal cavity (four fold; i.e. 48 h) were observed with NE-gels in comparison to CA solution (i.e. 12 h). In vitro nasal permeation study showed 10 folds enhancement of percentage drug permeation across the nasal mucosa in comparison to extract solution while three folds increase in free radical scavenging activity was observed by NE-gel (i.e. 48 h) in comparison to nanoemulsion (i.e. 24 h), respectively. Extensive in vitro investigation established these nanocarriers as suitable nanoformulations for brain targeting of water insoluble phytochemicals.
机译:本研究的目的是开发一种通过鼻膜持续释放植物治疗药物的制剂,以用于脑靶向治疗(抗阿尔茨海默氏病),以克服其滞留时间短和鼻通透性差的问题。使用在凝胶(NE-gels)中包含纳米乳液的双重方法来实现利用生物相容性生物材料的目标。表征了纳米乳液的粒度和ζ电势。载有积雪草(CA)提取物的NE凝胶是使用Carbopol?开发的。 934和具有流变学特性(可扩展性,粘度),药物释放和延长的抗氧化剂特性。进行体外鼻渗透和自由基清除活性以研究其预期的持续药理反应。随着Carbopol含量的增加,发现NE-凝胶的粘度增加至高达6237.3±1.1cp,这不利地影响了NE-凝胶的铺展性(3.06±0.98)。与CA溶液相比,NE-gels观察到CA提取物跨鼻膜的持续释放(四倍;长达48小时)的增强以及在鼻腔中的保留时间(四倍;即48 h)的增强。 12小时)。体外鼻渗透研究表明,与提取液相比,整个鼻粘膜的药物渗透百分数提高了10倍,而NE凝胶(即48小时)观察到的自由基清除活性比纳米乳剂(即24小时)提高了三倍。 ), 分别。广泛的体外研究将这些纳米载体确定为适合脑部靶向水不溶性植物化学物质的纳米制剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号